Evidence map›Paper›PMID 33453497›Full record

ArticlePsychiatry research2021

Prevalence and correlates of depression during the COVID-19 pandemic and the major role of stigmatization in low- and middle-income countries: A multinational cross-sectional study.

Jude Mary Cénat, Pari-Gole Noorishad, Cyrille Kossigan Kokou-Kpolou, Rose Darly Dalexis, Saba Hajizadeh, Mireille Guerrier, Lewis Ampidu Clorméus, Jacqueline Bukaka, Jean-Pierre Birangui, Kouami Adansikou and 4 more

Abstract read
In one paragraph

Article in Psychiatry research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jude Mary CénatSchool of psychology, University of Ottawa, Ontario, Canada. Electronic address: jcenat@uottawa.ca.
Pari-Gole NoorishadSchool of psychology, University of Ottawa, Ontario, Canada.
Cyrille Kossigan Kokou-KpolouSchool of psychology, University of Ottawa, Ontario, Canada; University of Picardie Jules Verne, Amiens, France.
Rose Darly DalexisInterdisciplinary School of Health Sciences, University of Ottawa, Ontario, Canada.
Saba HajizadehSchool of psychology, University of Ottawa, Ontario, Canada.
Mireille GuerrierSchool of psychology, University of Ottawa, Ontario, Canada.
Lewis Ampidu ClorméusUniversity of State of Haiti, Port-au-Prince, Haiti.
Jacqueline BukakaUniversity of Kinshasa, Kinshasa, Democratic Republic of the Congo.
Jean-Pierre BiranguiUniversity of Lubumbashi, Lubumbashi, Democratic Republic of the Congo.
Kouami AdansikouUniversité de Lomé, Lomé, Togo.
Assumpta NdengeyingomaUniversité du Québec en Outaouais, Canada.
Vincent SeziberaUniversity of Rwanda, Rwanda.
Daniel DerivoisUniversité Bourgogne Franche Comté, Dijon, France.
Cécile RousseauMcGill University, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesCurrently, there is little data on the mental health consequences of the COVID-19 pandemic in low- and middle-income countries (LMICs). This study aims to examine the pooled and separate prevalence and determinants of depression during the pandemic in samples from four LMICs.

methodsParticipants (N= 1267, 40.9% women) were recruited from the Democratic Republic of the Congo (DRC), Haiti, Rwanda, and Togo. They completed an online cross-sectional survey on sociodemographics, exposure and stigmatization related to COVID-19, the Hopkins Symptom Checklist depression subscale, and the Connor-Davidson Resilience Scale-2.

resultsThe pooled prevalence for depression symptoms was 24.3% (95% CI: 22.08-26.79%), with significant differences across countries. Younger age, gender (women), and high levels of exposure and stigmatization related to COVIID-19, and resilience were associated with depression in the pooled data. There were significant variations at the country level. Stigmatization (but not exposure to COVID-19 and resilience) was a strong predictor among the four countries.

conclusionsThe prevalence of depression symptoms in the LMICs are similar to those reported in China and in most high-income countries during the pandemic. The findings emphasize the need for implementing non-fear-based education programs during epidemics to reduce stigmatization.

Indexed as

SARS-CoV-2Social StigmaAdultAnxietyCOVID-19Cross-Sectional StudiesDemocratic Republic of the CongoDepressionEducational StatusFemaleHaitiHumansIncomeMaleMental HealthMiddle AgedCOVID-19DepressionDR Congo, Haiti, Rwanda and TogoResilienceStigmatization

Identifiers

PMID33453497
PMCPMC7837092

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.